Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Sesame Care vs Mixx Health & Wellness

Two GLP-1 desks, one scoreboard. We put Sesame Care and Mixx Health & Wellness head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 4 · Grade B+

Sesame Care

Visit Sesame Care Full brief →
vs
No. 277 · Grade C

Mixx Health & Wellness

Visit Mixx Health & Wellness Full brief →

The verdict

Sesame Care takes this head-to-head.

Sesame Care scores 87 to 63 on our six-factor Brief Score — An established national telehealth marketplace with the widest real brand-name GLP-1 access on the board — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

That doesn't make Mixx Health & Wellness a bad call — it's best for readers who want low-entry compounded glp-1 with $0 consults and a named pharmacy partner. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
84
48
Supply Reliability
92
66
Transparency
94
88
Access Breadth
84
54
Clinical Oversight
80
76
Track Record
92
42
Sesame CareBrief Score 87 · 63Mixx Health & Wellness

Price, coverage & the tracker

Sesame CareMixx Health & Wellness
Brief Score87/100 (B+)63/100 (C)
SemaglutideFrom $149/mo (brand Wegovy pill)Not disclosed
TirzepatideBrand Zepbound (price varies)Not disclosed
CoverageNationwide marketplace44 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

Sesame Care: Marketplace pricing is set per provider rather than one desk rate; the brand-name Wegovy pill line held its ~$149 entry this cycle.

Mixx Health & Wellness: New to the tracker on 1 August 2026. The published line reads From $120/mo (compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.